Study collaborators at the NIH's National Institute of Allergy and Infectious Diseases (NIAID) found that treatment with mAb 3A6 can benefit non-human primates in advanced stages of Ebola virus ...

Study collaborators at the NIH's National Institute of Allergy and Infectious Diseases (NIAID) found that treatment with mAb 3A6 can benefit non-human primates in advanced stages of Ebola virus ...

The National Institutes of Health's initial trial found the experimental vaccine for the Ebola virus so far is safe for humans and produced an immune response. Researches found anti-Ebola ...

for a new vaccine that has enough preclinical safety and manufacturing quality control to be brought into the field at such an early stage," former ... vaccines for Ebola Zaire, smallpox, Japanese ...

Uganda has had multiple Ebola outbreaks, including one in 2000 that killed hundreds. The 2014-16 Ebola outbreak in West Africa killed more than 11,000 people, the disease’s largest death toll.

Ebola is spread by contact with the bodily fluids of an infected person or contaminated materials. Symptoms include fever, vomiting, diarrhea, muscle pain and at times internal and external bleeding.

Study collaborators at the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) found that treatment with mAb 3A6 can benefit non-human primates in advanced stages of Ebola virus ...